HB Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
HB Wealth Management's PFE Position: Q2 2026 in Review
HB Wealth Management increased its Pfizer (PFE) stake by 1.8% in Q2 2026, buying an estimated $166K and bringing the position to 350,351 shares worth $8.44M. The position accounts for 0.05% of the portfolio, ranked #191.
HB Wealth Management first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $17.5M in Q4 2022. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- HB Wealth Management held 350,351 shares of Pfizer worth $8.44M as of Q2 2026.
- HB Wealth Management bought 6,362 Pfizer shares in Q2 2026, an estimated $166K.
- Pfizer made up 0.05% of HB Wealth Management's portfolio in Q2 2026, its #191 holding.
- HB Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- HB Wealth Management's Pfizer position peaked at $17.5M in Q4 2022.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.